Novoprotein Scientific Inc. (SHA:688137)
132.20
-7.21 (-5.17%)
At close: Oct 19, 2026
Novoprotein Scientific Company Description
Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technology solutions for biopharmaceuticals enterprises.
The company offers mRNA vaccine drug raw materials, immunodiagnostic and molecular diagnostic raw materials, gene and cell therapy, molecular research reagents, cytokines, target proteins, cell lines, reference antibody, recombinant antibodies, enzymes and reagents, matrix gel and culture medium, and protein and virus research related products.
It offers its products and services in the fields of biopharmaceuticals, mRNA vaccines and drugs, in vitro diagnostics, basic research of life sciences, and other areas.
Novoprotein Scientific Inc. was founded in 2009 and is headquartered in Suzhou, China.
Novoprotein Scientific Inc.
| Country | China |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 696 |
| CEO | Huaxing Zhu |
Contact Details
Address: No.228, Yunchuang Road Suzhou, 215299 China | |
| Phone | 86 512 6391 9116 |
| Website | novoprotein.com.cn |
Stock Details
| Ticker Symbol | 688137 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005NZ4 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Huaxing Zhu | Founder, Chairman and GM |
| Dongye Zhang | Accounting Supervisor and Chief Financial Officer |
| Yingming Wang | Deputy GM and Director |
| Yujian Zhao | Deputy GM and Director |
| Duqiang Wang | Deputy GM, Secretary and Director |